TrinScreen HIV order signals renewed strength in global HIV testing market- Company also reports a key milestone of Adjusted EBITDA1positive operations in Q3 2025 and expects to ...
Guardant360® CDx is the first companion diagnostic to be approved in Japan to identify ESR1 mutations in patients with hormone receptor-positive, HER2-negative breast cancer for treatment with imlunes ...
We searched for evidence from studies known as 'clinical trials' that compared rapid TB tests with traditional methods of testing for TB, like smear microscopy and culture. We summarised the findings ...
Jairam Sampath, CFO of Kaynes Technology, said the company remains focused on its long-term goals, including achieving $1 ...
Thank you, and welcome to Micron Technology's Fiscal First Quarter 2026 Post-Earnings Analyst Call. On the call with me today are Sumit Sadana, Micron's Chief Business Officer; Manish Bhatia, EVP of ...
Scientists at Northern Arizona University are developing a promising new way to detect Alzheimer’s disease earlier than ever before—by tracking how the brain uses sugar. Using tiny particles in the ...
Experts predict a test measuring p-tau217 in blood plasma may become a standard screening tool for Alzheimer’s disease in ...
Kaynes Technology India Ltd's stock has corrected 16% since Kotak Institutional Equities’ 3 December report flagged potential ...
CHENGDU, China, Nov. 24, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company", 6990.HK) announced today that the Independent Data Monitoring Committee (IDMC) concluded ...
CHENGDU, China, Nov. 24, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company", 6990.HK) announced today that the Independent Data Monitoring Committee (IDMC) concluded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback